logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Md Farma Closes Series A Funding And Changes Name To Corganics As The Company Expands Clinical Cannabinoid (Cbd) Product Lines Sold Only In Healthcare Facilities

Nov 30, 2021•about 4 years ago

Round Type

series a

Dallas

Description

MD Farma, healthcare professionals' most trusted and recommended clinical cannabinoid (CBD) company, announced today a Series A investment from Altacrest Capital. The funding will support MD Farma's expansion of its clinical product portfolio, only available through healthcare professionals, and the company's branding strategy under its new name, Corganics. The new name reflects the company's commitment to all-natural, organic therapeutic products patients are actively seeking through healthcare professionals.

Company Information

Company

Md Farma

Location

Dallas, Georgia, United States

About

Additionally, the company will acquire Relief™, a leading natural, non-CBD, topical pain analgesic product portfolio. With this funding round the company will accelerate its ability to reach more healthcare professionals by amplifying education on cannabinoid therapy, expanding operations, increasing its commercial footprint and investing in research and development innovations.